We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
OS9
HPA
RESOURCES
  • TISSUE
  • BRAIN
  • SINGLE CELL
  • SUBCELLULAR
  • CANCER
  • BLOOD
  • CELL LINE
  • STRUCTURE & INTERACTION
ABOUT
  • INTRODUCTION
  • HISTORY
  • ORGANIZATION
  • PUBLICATIONS
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • ACKNOWLEDGMENTS
  • CONTACT
NEWS
  • NEWS ARTICLES
  • PRESS ROOM
LEARN
  • DICTIONARY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
  • METHODS
  • EDUCATIONAL VIDEOS
DATA
  • DOWNLOADABLE DATA
  • PUBLICATION DATA
  • RELEASE HISTORY
HELP
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • HELP & FAQ
  • PRIVACY STATEMENT
  • LICENCE & CITATION
Fields »
Search result

Field
Term
Gene name
Class
Subclass
Class
Keyword
Chromosome
External id
Tissue
Cell type
Expression
Antibody panel
Tissue
Main location
Patient ID
Annotation
Tissue
Category
Tau score
Cluster
Reliability
Brain region
Category
Tau score
Brain region
Category
Tau score
Brain region
Category
Tau score
Cluster
Reliability
Tissue
Cell type
Enrichment
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell type
Category
Tau score
Cell lineage
Category
Tau score
Cluster
Cluster
Location
Searches
Location
Cell line
Class
Type
Phase
Reliability
Cancer
Prognosis
Cancer
Category
Cancer
Category
Tau score
Cluster
Variants
Interacting gene (ensg_id)
Type
Number of interactions
Pathway
Category
Score
Score
Score
Validation
Validation
Validation
Validation
Antibodies
Data type
Column


  • SUMMARY

  • TISSUE

  • BRAIN

  • SINGLE CELL

  • SUBCELL

  • CANCER

  • BLOOD

  • CELL LINE

  • STRUCT & INT

  • OS9
CANCER LIVER CANCER Show tissue menu
BREAST CANCER CARCINOID CERVICAL CANCER COLORECTAL CANCER ENDOMETRIAL CANCER GLIOMA HEAD AND NECK CANCER LIVER CANCER LUNG CANCER LYMPHOMA
MELANOMA OVARIAN CANCER PANCREATIC CANCER PROSTATE CANCER RENAL CANCER SKIN CANCER STOMACH CANCER TESTIS CANCER THYROID CANCER UROTHELIAL CANCER
LIHC TCGA LIHC VALIDATION PROTEIN LIHC CPTAC PROTEIN EXPRESSION
ANTIBODIES
AND
VALIDATION
Dictionary
Liver cancer
Human cancer
Liver hepatocellular carcinoma
LIVER HEPATOCELLULAR CARCINOMA (TCGA) - Interactive survival scatter ploti

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisi

Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.

OS9 is not prognostic in Liver Hepatocellular Carcinoma (TCGA)


Stage:


Survival analysis
Current cut offi

Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.

:
Best expression cut offi

Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .

When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.

: 163.16
Median expressioni

Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.

: N/A
Median follow up timei

Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.

: N/A
P scorei

Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.

N/A
5-year survival highi

5-year survival for patients with higher expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
5-year survival lowi

5-year survival for patients with lower expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
TCGA RNA samplesi

RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .

Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.

Average pTPM 189.0
Number of samples 362
Samples
Sample Description pTPM
TCGA-2Y-A9GT-01A 51 years, male, white, stage:Stage I, dead, 1624 days 924.5
TCGA-ZP-A9D2-01A 51 years, male, white, stage:'--, dead, 765 days 740.5
TCGA-ZS-A9CF-01A 64 years, male, white, stage:Stage II, alive, 2412 days 481.5
TCGA-ED-A7PZ-01A 61 years, male, asian, stage:Stage II, alive, 6 days 478.5
TCGA-CC-A7IJ-01A 56 years, male, asian, stage:Stage II, alive, 382 days 452.8
TCGA-DD-A4NH-01A 65 years, female, white, stage:Stage IIIB, alive, 917 days 405.6
TCGA-DD-AADY-01A 55 years, female, asian, stage:Stage I, alive, 555 days 390.3
TCGA-2Y-A9H9-01A 70 years, male, white, stage:Stage I, alive, 697 days 386.1
TCGA-2Y-A9H0-01A 49 years, male, white, stage:Stage IIIA, alive, 3675 days 381.9
TCGA-BW-A5NO-01A 50 years, male, black or african american, stage:Stage IIIA, alive, 20 days 376.9
TCGA-G3-A6UC-01A 65 years, male, white, stage:Stage IIIB, alive, 671 days 365.4
TCGA-DD-A73E-01A 66 years, male, white, stage:Stage I, alive, 44 days 362.7
TCGA-UB-A7MA-01A 62 years, female, white, stage:Stage II, alive, 848 days 356.4
TCGA-RC-A7SK-01A 59 years, male, asian, stage:Stage I, alive, 472 days 353.4
TCGA-FV-A3I1-01A 81 years, female, white, stage:Stage II, dead, 247 days 353.2
TCGA-UB-A7ME-01A 51 years, male, asian, stage:Stage I, alive, 486 days 352.1
TCGA-FV-A3I0-01A 76 years, female, white, stage:Stage II, alive, 848 days 351.6
TCGA-CC-5263-01A 35 years, male, asian, stage:Stage IIIA, dead, 129 days 351.3
TCGA-G3-A7M9-01A 70 years, male, white, stage:Stage IIIB, dead, 56 days 344.3
TCGA-DD-AAD3-01A 43 years, male, asian, stage:Stage I, alive, 1295 days 343.4
TCGA-GJ-A9DB-01A 68 years, male, white, stage:Stage I, dead, 67 days 330.8
TCGA-LG-A9QC-01A 48 years, male, white, stage:Stage I, alive, 425 days 327.4
TCGA-DD-A11D-01A 57 years, female, white, stage:Stage I, dead, 1560 days 323.7
TCGA-3K-AAZ8-01A 65 years, male, black or african american, stage:Stage IIIB, alive, 396 days 322.1
TCGA-ZP-A9CV-01A 59 years, male, white, stage:'--, dead, 1088 days 319.1
TCGA-DD-AACY-01A 61 years, male, asian, stage:Stage I, alive, 1450 days 317.0
TCGA-CC-A9FW-01A 68 years, male, asian, stage:Stage IIIA, alive, 248 days 314.4
TCGA-DD-AADV-01A 50 years, male, asian, stage:Stage I, alive, 574 days 314.3
TCGA-G3-AAV4-01A 83 years, female, white, stage:Stage I, dead, 27 days 310.4
TCGA-GJ-A6C0-01A 75 years, female, white, stage:Stage II, dead, 31 days 309.6
TCGA-CC-A5UD-01A 45 years, male, asian, stage:Stage IIIA, dead, 304 days 308.5
TCGA-G3-A7M6-01A 60 years, female, white, stage:Stage I, alive, 632 days 306.4
TCGA-DD-A73C-01A 65 years, female, white, stage:Stage IIIA, alive, 701 days 299.5
TCGA-MI-A75I-01A 61 years, male, black or african american, stage:'--, alive, 630 days 298.0
TCGA-DD-A11C-01A 69 years, male, white, stage:Stage I, alive, 662 days 296.6
TCGA-BC-A10U-01A 69 years, male, white, stage:'--, dead, 837 days 296.3
TCGA-DD-AADP-01A 45 years, male, asian, stage:Stage I, alive, 458 days 292.3
TCGA-CC-5264-01A 71 years, male, asian, stage:Stage IIIA, dead, 102 days 292.2
TCGA-2Y-A9GS-01A 58 years, male, white, stage:'--, dead, 724 days 291.0
TCGA-DD-AAEK-01A 51 years, male, asian, stage:Stage II, alive, 1067 days 289.0
TCGA-EP-A2KA-01A 52 years, female, white, stage:Stage IIIA, dead, 627 days 287.4
TCGA-G3-AAV7-01A 38 years, male, asian, stage:Stage II, alive, 361 days 285.8
TCGA-DD-A118-01A 77 years, female, white, stage:Stage II, alive, 3437 days 284.5
TCGA-BC-A10Y-01A 76 years, male, white, stage:'--, dead, 711 days 282.4
TCGA-HP-A5N0-01A 90 years, female, stage:'--, dead, 752 days 281.3
TCGA-DD-A1EB-01A 72 years, female, stage:Stage I, alive, 2017 days 281.1
TCGA-BC-A217-01A 75 years, female, white, stage:Stage II, dead, 1397 days 280.8
TCGA-DD-AACK-01A 70 years, male, asian, stage:Stage I, alive, 9 days 279.9
TCGA-CC-A7IK-01A 59 years, male, asian, stage:Stage IIIA, dead, 262 days 279.2
TCGA-FV-A2QR-01A 75 years, male, white, stage:Stage I, dead, 581 days 276.4
TCGA-BC-A10R-01A 66 years, female, white, stage:'--, dead, 308 days 276.3
TCGA-LG-A6GG-01A 79 years, female, white, stage:Stage II, alive, 387 days 276.0
TCGA-DD-A1EJ-01A 71 years, female, white, stage:Stage IIIC, dead, 1005 days 275.7
TCGA-XR-A8TG-01A 58 years, male, white, stage:Stage I, alive, 898 days 275.1
TCGA-ED-A7PX-01A 48 years, female, asian, stage:Stage II, alive, 6 days 272.0
TCGA-UB-A7MC-01A 59 years, male, white, stage:Stage IIIA, alive, 500 days 271.0
TCGA-ED-A7XP-01A 53 years, female, asian, stage:Stage II, alive, 400 days 269.9
TCGA-2Y-A9H2-01A 64 years, female, white, stage:Stage I, alive, 1731 days 268.3
TCGA-DD-AACV-01A 53 years, male, asian, stage:Stage I, alive, 1531 days 267.6
TCGA-FV-A3R2-01A 75 years, male, white, stage:Stage I, dead, 194 days 267.4
TCGA-ZP-A9D0-01A 67 years, female, black or african american, stage:'--, alive, 1091 days 266.7
TCGA-DD-A114-01A 42 years, male, black or african american, stage:Stage II, dead, 1149 days 261.8
TCGA-5C-A9VG-01A 58 years, male, white, stage:Stage II, alive, 328 days 261.1
TCGA-DD-A115-01A 53 years, male, white, stage:Stage IIIA, dead, 2542 days 261.0
TCGA-4R-AA8I-01A 66 years, male, white, stage:Stage II, dead, 262 days 260.7
TCGA-DD-AAW0-01A 54 years, male, asian, stage:Stage I, alive, 2015 days 259.5
TCGA-UB-A7MD-01A 67 years, male, black or african american, stage:Stage I, dead, 52 days 254.7
TCGA-RC-A7SB-01A 53 years, male, asian, stage:Stage II, alive, 588 days 253.8
TCGA-DD-A4NA-01A 67 years, female, white, stage:Stage IIIC, alive, 1008 days 253.3
TCGA-BC-A3KF-01A 66 years, female, white, stage:Stage I, alive, 8 days 253.3
TCGA-2Y-A9GZ-01A 82 years, female, white, stage:Stage II, dead, 848 days 253.3
TCGA-XR-A8TE-01A 16 years, male, white, stage:Stage IIIA, alive, 925 days 251.3
TCGA-2Y-A9GV-01A 54 years, female, white, stage:Stage I, dead, 2532 days 250.4
TCGA-DD-AAVY-01A 56 years, male, asian, stage:Stage IIIA, alive, 1970 days 249.9
TCGA-G3-A7M5-01A 76 years, male, asian, stage:Stage I, alive, 447 days 249.4
TCGA-DD-A4ND-01A 56 years, female, white, stage:Stage I, alive, 2746 days 247.0
TCGA-DD-A11B-01A 73 years, male, white, stage:Stage I, dead, 14 days 245.9
TCGA-DD-A1EH-01A 23 years, male, white, stage:Stage III, alive, 1495 days 245.2
TCGA-EP-A12J-01A 62 years, male, black or african american, stage:Stage I, alive, 570 days 244.3
TCGA-DD-AACU-01A 59 years, male, asian, stage:Stage I, alive, 1567 days 243.9
TCGA-DD-A39W-01A 29 years, female, white, stage:Stage III, dead, 827 days 240.7
TCGA-2Y-A9HB-01A 66 years, male, stage:Stage I, alive, 260 days 239.7
TCGA-2Y-A9GU-01A 55 years, female, white, stage:Stage I, alive, 1939 days 239.5
TCGA-BC-A10T-01A 76 years, male, white, stage:'--, dead, 837 days 239.2
TCGA-2Y-A9HA-01A 70 years, male, white, stage:Stage II, dead, 36 days 238.6
TCGA-DD-AADG-01A 70 years, male, asian, stage:Stage IIIA, alive, 1145 days 238.3
TCGA-ED-A5KG-01A 60 years, female, asian, stage:Stage II, alive, 854 days 237.2
TCGA-ZS-A9CE-01A 79 years, female, white, stage:Stage II, alive, 1241 days 234.0
TCGA-FV-A496-01A 84 years, female, white, stage:Stage I, alive, 10 days 232.1
TCGA-XR-A8TC-01A 43 years, female, white, stage:Stage I, alive, 1339 days 231.9
TCGA-G3-A5SI-01A 44 years, male, asian, stage:Stage II, dead, 768 days 230.6
TCGA-ED-A7XO-01A 29 years, male, asian, stage:Stage IIIA, alive, 427 days 230.4
TCGA-UB-A7MB-01A 24 years, male, white, stage:Stage II, alive, 601 days 229.1
TCGA-DD-AADL-01A 58 years, male, asian, stage:Stage I, alive, 636 days 228.7
TCGA-UB-AA0U-01A 60 years, male, white, stage:Stage II, alive, 327 days 228.1
TCGA-BC-A10Z-01A 62 years, female, white, stage:Stage I, dead, 34 days 227.5
TCGA-DD-A4NK-01A 80 years, female, white, stage:Stage IIIA, dead, 1210 days 226.1
TCGA-BC-A5W4-01A 69 years, male, white, stage:Stage IIIA, dead, 547 days 223.3
TCGA-5R-AAAM-01A 65 years, female, white, stage:Stage II, dead, 46 days 221.8
TCGA-DD-AADD-01A 51 years, male, asian, stage:Stage I, alive, 1231 days 219.9
TCGA-DD-A113-01A 55 years, female, white, stage:Stage II, alive, 2425 days 219.7
TCGA-DD-AAVS-01A 56 years, male, asian, stage:Stage I, alive, 1823 days 219.4
TCGA-DD-AAE2-01A 51 years, male, asian, stage:Stage I, alive, 638 days 218.7
TCGA-CC-A7IL-01A 61 years, male, asian, stage:Stage IIIA, dead, 278 days 218.0
TCGA-DD-A3A5-01A 66 years, female, white, stage:Stage III, dead, 3125 days 217.3
TCGA-2Y-A9H8-01A 85 years, female, white, stage:'--, dead, 633 days 216.2
TCGA-RC-A6M6-01A 75 years, male, white, stage:Stage II, alive, 9 days 215.7
TCGA-DD-A1EK-01A 64 years, female, white, stage:Stage IVB, dead, 558 days 212.6
TCGA-DD-A1EF-01A 57 years, female, white, stage:Stage I, dead, 394 days 212.4
TCGA-G3-A5SL-01A 70 years, male, white, stage:Stage II, alive, 621 days 212.1
TCGA-CC-5260-01A 61 years, female, asian, stage:Stage IIIC, dead, 87 days 211.7
TCGA-DD-AACF-01A 68 years, male, asian, stage:Stage I, dead, 365 days 211.5
TCGA-DD-A4NF-01A 72 years, male, white, stage:Stage I, alive, 942 days 211.5
TCGA-K7-AAU7-01A 61 years, male, white, stage:Stage II, alive, 359 days 211.1
TCGA-BC-A8YO-01A 66 years, female, white, stage:Stage IIIC, alive, 562 days 210.7
TCGA-DD-AAD0-01A 73 years, female, asian, stage:Stage I, alive, 137 days 210.4
TCGA-CC-A8HU-01A 39 years, female, asian, stage:Stage IIIA, dead, 344 days 209.5
TCGA-ED-A8O5-01A 59 years, female, asian, stage:Stage IIIA, alive, 406 days 208.2
TCGA-KR-A7K8-01A 57 years, male, stage:Stage I, alive, 906 days 208.0
TCGA-DD-AADW-01A 48 years, male, asian, stage:Stage I, alive, 587 days 207.4
TCGA-T1-A6J8-01A 68 years, male, white, stage:'--, alive, 23 days 206.7
TCGA-DD-A4NV-01A 61 years, male, white, stage:Stage IIIA, alive, 2398 days 206.5
TCGA-G3-AAV2-01A 50 years, male, white, stage:Stage I, alive, 372 days 206.3
TCGA-DD-A4NJ-01A 54 years, female, white, stage:Stage II, alive, 928 days 205.5
TCGA-G3-AAV3-01A 58 years, female, white, stage:Stage II, alive, 412 days 205.4
TCGA-BC-A10Q-01A 72 years, female, white, stage:'--, dead, 1135 days 205.3
TCGA-CC-A7IH-01A 58 years, male, asian, stage:Stage IIIA, alive, 365 days 204.3
TCGA-G3-A3CK-01A 61 years, male, asian, stage:Stage I, alive, 585 days 203.6
TCGA-XR-A8TF-01A 74 years, male, white, stage:Stage I, dead, 693 days 203.5
TCGA-G3-AAV1-01A 51 years, male, asian, stage:Stage IIIC, dead, 359 days 203.3
TCGA-DD-AAC8-01A 72 years, male, asian, stage:Stage I, dead, 16 days 203.3
TCGA-CC-A3M9-01A 45 years, male, asian, stage:Stage IIIA, dead, 300 days 203.3
TCGA-ZS-A9CG-01A 55 years, male, white, stage:Stage II, alive, 341 days 203.0
TCGA-G3-A25Y-01A 52 years, female, asian, stage:Stage I, dead, 452 days 202.3
TCGA-DD-A3A4-01A 37 years, male, white, stage:Stage IIIA, dead, 612 days 202.3
TCGA-ZP-A9CY-01A 66 years, female, white, stage:'--, alive, 782 days 201.7
TCGA-EP-A26S-01A 70 years, male, white, stage:Stage I, alive, 608 days 201.3
TCGA-2Y-A9H7-01A 81 years, female, white, stage:Stage I, alive, 1168 days 201.2
TCGA-QA-A7B7-01A 48 years, male, black or african american, stage:Stage II, alive, 94 days 200.0
TCGA-DD-AADC-01A 53 years, male, asian, stage:Stage I, dead, 425 days 199.8
TCGA-DD-AAD2-01A 66 years, male, asian, stage:Stage I, alive, 658 days 199.5
TCGA-DD-A4NN-01A 56 years, female, white, stage:Stage I, dead, 899 days 199.0
TCGA-DD-AAVW-01A 35 years, male, asian, stage:Stage I, alive, 2317 days 196.8
TCGA-2Y-A9H6-01A 68 years, female, white, stage:Stage I, alive, 357 days 196.5
TCGA-FV-A3R3-01A 38 years, female, white, stage:Stage I, dead, 366 days 195.8
TCGA-DD-AACA-01A 65 years, male, asian, stage:Stage I, alive, 2301 days 195.1
TCGA-G3-A5SJ-01A 59 years, male, white, stage:Stage I, alive, 698 days 194.7
TCGA-DD-AAW3-01A 69 years, male, asian, stage:Stage I, alive, 1633 days 193.0
TCGA-CC-A3MB-01A 36 years, male, asian, stage:Stage IIIA, dead, 315 days 192.2
TCGA-DD-A73F-01A 77 years, female, white, stage:Stage I, alive, 1085 days 191.8
TCGA-G3-A7M8-01A 31 years, male, asian, stage:Stage I, alive, 430 days 191.5
TCGA-DD-A3A8-01A 75 years, male, white, stage:Stage II, dead, 11 days 190.8
TCGA-DD-A73B-01A 72 years, female, white, stage:Stage I, dead, 283 days 189.7
TCGA-DD-AACZ-01A 63 years, female, asian, stage:Stage I, dead, 171 days 189.0
TCGA-DD-AACJ-01A 75 years, male, asian, stage:Stage II, alive, 2102 days 188.6
TCGA-O8-A75V-01A 54 years, male, stage:Stage I, alive, 538 days 188.5
TCGA-2Y-A9GW-01A 64 years, male, white, stage:Stage I, dead, 1271 days 187.6
TCGA-DD-A1EA-01A 68 years, male, asian, stage:Stage II, alive, 2415 days 187.5
TCGA-2Y-A9H5-01A 59 years, female, white, stage:Stage I, dead, 555 days 186.2
TCGA-DD-AAW1-01A 55 years, male, asian, stage:Stage IIIA, alive, 1989 days 186.1
TCGA-DD-AAW2-01A 69 years, male, asian, stage:Stage I, alive, 1855 days 185.5
TCGA-DD-AAEI-01A 72 years, male, asian, stage:Stage I, alive, 1531 days 185.4
TCGA-YA-A8S7-01A 68 years, male, white, stage:Stage IIIA, dead, 412 days 184.3
TCGA-FV-A23B-01A 70 years, female, white, stage:Stage II, dead, 1852 days 183.4
TCGA-BC-A10W-01A 50 years, male, asian, stage:'--, dead, 91 days 183.3
TCGA-DD-AADB-01A 51 years, male, asian, stage:Stage I, alive, 1242 days 181.7
TCGA-DD-AAVV-01A 56 years, male, asian, stage:Stage II, alive, 2455 days 181.4
TCGA-DD-A1EE-01A 73 years, male, white, stage:Stage IIIA, dead, 349 days 181.2
TCGA-DD-A4NE-01A 75 years, female, white, stage:Stage IIIA, dead, 660 days 181.0
TCGA-G3-A25S-01A 64 years, male, white, stage:Stage I, dead, 416 days 180.6
TCGA-PD-A5DF-01A 58 years, female, white, stage:Stage IIIB, dead, 639 days 180.5
TCGA-DD-AACS-01A 39 years, male, asian, stage:Stage I, alive, 1804 days 179.7
TCGA-BD-A3EP-01A 75 years, female, black or african american, stage:Stage I, alive, 409 days 179.5
TCGA-ZP-A9D4-01A 64 years, female, white, stage:'--, alive, 395 days 178.9
TCGA-ZP-A9CZ-01A 72 years, male, asian, stage:'--, alive, 706 days 176.9
TCGA-DD-AAD1-01A 51 years, female, asian, stage:Stage I, alive, 564 days 176.3
TCGA-G3-A3CG-01A 80 years, male, white, stage:Stage I, alive, 673 days 175.5
TCGA-2Y-A9H4-01A 68 years, male, black or african american, stage:Stage I, alive, 1452 days 175.1
TCGA-ED-A82E-01A 60 years, female, asian, stage:Stage IIIA, alive, 408 days 174.5
TCGA-DD-A4NS-01A 61 years, female, white, stage:Stage I, dead, 2456 days 174.5
TCGA-ED-A627-01A 74 years, male, white, stage:Stage I, alive, 423 days 174.4
TCGA-CC-5261-01A 44 years, male, asian, stage:Stage II, dead, 97 days 174.1
TCGA-DD-A4NR-01A 85 years, female, white, stage:Stage I, dead, 9 days 172.5
TCGA-DD-AAC9-01A 51 years, male, asian, stage:Stage I, alive, 347 days 172.3
TCGA-UB-A7MF-01A 56 years, male, white, stage:Stage IIIA, dead, 214 days 172.3
TCGA-G3-A25Z-01A 58 years, male, asian, stage:Stage I, alive, 655 days 171.5
TCGA-DD-A4NI-01A 67 years, male, white, stage:Stage II, alive, 816 days 171.2
TCGA-MR-A520-01A 58 years, male, white, stage:Stage I, alive, 229 days 170.6
TCGA-DD-AAE7-01A 72 years, male, asian, stage:Stage I, alive, 644 days 170.3
TCGA-DD-A3A9-01A 64 years, female, white, stage:Stage IVB, dead, 931 days 169.7
TCGA-BC-A69H-01A 64 years, male, white, stage:Stage II, alive, 444 days 168.6
TCGA-CC-A1HT-01A 50 years, male, asian, stage:Stage IIIA, dead, 101 days 168.3
TCGA-ED-A4XI-01A 58 years, male, asian, stage:Stage II, alive, 819 days 168.2
TCGA-5R-AA1C-01A 57 years, male, white, stage:Stage II, alive, 520 days 166.8
TCGA-K7-A5RF-01A 64 years, male, white, stage:Stage I, alive, 631 days 166.4
TCGA-BD-A2L6-01A 69 years, male, white, stage:'--, alive, 1363 days 166.4
TCGA-MI-A75E-01A 61 years, male, white, stage:Stage IIIC, alive, 507 days 165.9
TCGA-DD-AA3A-01A 81 years, female, white, stage:Stage I, dead, 410 days 165.8
TCGA-DD-A1EG-01A 76 years, male, white, stage:Stage I, dead, 1372 days 165.8
TCGA-2Y-A9GY-01A 64 years, female, white, stage:Stage II, dead, 757 days 165.7
TCGA-DD-A1EL-01A 23 years, male, black or african american, stage:Stage II, dead, 415 days 165.5
TCGA-DD-AACN-01A 32 years, male, asian, stage:Stage I, alive, 1302 days 164.7
TCGA-BC-A10X-01A 52 years, female, white, stage:Stage IIIA, dead, 770 days 164.6
TCGA-GJ-A3OU-01A 59 years, male, white, stage:Stage I, alive, 879 days 164.2
TCGA-G3-AAV6-01A 53 years, female, white, stage:Stage IIIA, dead, 65 days 163.9
TCGA-5C-A9VH-01A 70 years, male, white, stage:Stage I, alive, 322 days 163.5
TCGA-BC-A112-01A 80 years, male, white, stage:'--, dead, 153 days 163.2
TCGA-DD-AACW-01A 43 years, male, asian, stage:Stage I, alive, 1424 days 163.1
TCGA-RG-A7D4-01A 69 years, male, black or african american, stage:Stage II, alive, 1098 days 162.9
TCGA-CC-A5UE-01A 48 years, male, asian, stage:Stage IIIB, dead, 272 days 162.8
TCGA-DD-AAVZ-01A 38 years, male, asian, stage:Stage I, alive, 1900 days 162.5
TCGA-DD-A1EI-01A 46 years, male, asian, stage:Stage I, alive, 183 days 161.7
TCGA-DD-AACX-01A 66 years, male, asian, stage:Stage II, alive, 170 days 161.3
TCGA-BC-A69I-01A 69 years, male, white, stage:Stage I, alive, 387 days 160.9
TCGA-DD-AAVQ-01A 38 years, male, asian, stage:Stage I, alive, 2728 days 160.7
TCGA-DD-A1EC-01A 20 years, female, white, stage:Stage I, alive, 602 days 159.1
TCGA-G3-A5SM-01A 58 years, male, white, stage:Stage II, alive, 520 days 158.5
TCGA-CC-5262-01A 67 years, male, asian, stage:Stage IIIC, dead, 103 days 157.8
TCGA-DD-A73D-01A 68 years, female, white, stage:Stage II, alive, 693 days 157.0
TCGA-DD-AACL-01A 66 years, female, asian, stage:Stage I, dead, 107 days 156.9
TCGA-BC-A3KG-01A 68 years, female, white, stage:Stage II, alive, 680 days 156.6
TCGA-ED-A66X-01A 35 years, male, asian, stage:Stage IIIA, alive, 406 days 156.6
TCGA-DD-A3A2-01A 76 years, female, white, stage:Stage I, dead, 2131 days 156.3
TCGA-5C-AAPD-01A 61 years, male, asian, stage:Stage II, alive, 20 days 156.2
TCGA-EP-A3RK-01A 73 years, male, white, stage:Stage IIIA, alive, 363 days 156.0
TCGA-MI-A75H-01A 77 years, male, white, stage:'--, alive, 747 days 155.9
TCGA-G3-A7M7-01A 65 years, male, white, stage:Stage I, alive, 361 days 154.8
TCGA-CC-A8HS-01A 18 years, male, asian, stage:Stage IIIC, dead, 300 days 154.6
TCGA-CC-A9FS-01A 55 years, male, asian, stage:Stage II, alive, 211 days 154.4
TCGA-G3-A3CI-01A 71 years, male, white, stage:Stage I, alive, 180 days 154.3
TCGA-DD-A4NO-01A 65 years, male, white, stage:Stage I, alive, 2245 days 154.1
TCGA-G3-A25X-01A 73 years, male, asian, stage:Stage II, alive, 1779 days 153.5
TCGA-DD-AAEG-01A 59 years, female, asian, stage:Stage I, alive, 719 days 153.4
TCGA-DD-A39Z-01A 43 years, female, stage:Stage II, dead, 601 days 153.3
TCGA-2Y-A9GX-01A 68 years, male, white, stage:Stage I, alive, 2442 days 153.3
TCGA-DD-A4NQ-01A 60 years, male, white, stage:Stage II, dead, 373 days 151.6
TCGA-DD-AADK-01A 68 years, female, asian, stage:Stage II, alive, 1049 days 151.4
TCGA-G3-A25U-01A 63 years, female, asian, stage:Stage I, alive, 1636 days 151.3
TCGA-ED-A97K-01A 54 years, male, asian, stage:Stage IIIA, alive, 6 days 150.8
TCGA-DD-A1ED-01A 68 years, male, white, stage:Stage I, alive, 2301 days 150.0
TCGA-DD-A3A1-01A 65 years, male, stage:Stage IIIA, dead, 233 days 149.9
TCGA-DD-AAE1-01A 52 years, male, asian, stage:Stage I, alive, 552 days 149.7
TCGA-G3-A25T-01A 45 years, female, white, stage:Stage IIIA, alive, 1553 days 147.6
TCGA-BC-A10S-01A 81 years, male, white, stage:'--, dead, 1423 days 147.6
TCGA-DD-AAVP-01A 48 years, male, asian, stage:Stage I, alive, 2752 days 147.1
TCGA-DD-AAEH-01A 73 years, male, asian, stage:Stage I, alive, 784 days 146.4
TCGA-EP-A2KC-01A 62 years, male, black or african american, stage:Stage I, dead, 19 days 146.3
TCGA-G3-AAV5-01A 67 years, male, white, stage:Stage II, alive, 354 days 145.8
TCGA-FV-A2QQ-01A 80 years, male, white, stage:Stage I, alive, 729 days 145.8
TCGA-UB-AA0V-01A 69 years, female, white, stage:Stage I, alive, 314 days 145.0
TCGA-G3-A25V-01A 68 years, male, white, stage:Stage I, alive, 860 days 144.1
TCGA-MI-A75G-01A 63 years, male, white, stage:Stage II, alive, 698 days 144.1
TCGA-KR-A7K0-01A 65 years, male, white, stage:Stage I, dead, 65 days 143.2
TCGA-DD-AAEE-01A 55 years, male, asian, stage:Stage I, alive, 810 days 142.8
TCGA-DD-AADI-01A 43 years, female, asian, stage:Stage I, alive, 1085 days 142.5
TCGA-BD-A3ER-01A 62 years, male, white, stage:Stage II, alive, 1115 days 142.1
TCGA-DD-AACT-01A 69 years, female, asian, stage:Stage I, alive, 1562 days 140.3
TCGA-RC-A6M4-01A 74 years, female, white, stage:Stage IIIA, alive, 22 days 139.6
TCGA-DD-AAE3-01A 50 years, male, asian, stage:Stage I, alive, 566 days 138.8
TCGA-NI-A8LF-01A 74 years, male, white, stage:Stage I, alive, 799 days 138.0
TCGA-ZP-A9D1-01A 56 years, female, white, stage:'--, alive, 21 days 137.5
TCGA-FV-A4ZQ-01A 52 years, male, white, stage:Stage I, alive, 12 days 137.1
TCGA-ZS-A9CD-01A 73 years, male, white, stage:Stage II, dead, 1386 days 135.3
TCGA-ED-A459-01A 47 years, male, asian, stage:Stage II, alive, 910 days 134.9
TCGA-DD-A73A-01A 71 years, male, white, stage:Stage I, alive, 728 days 134.6
TCGA-DD-AACP-01A 64 years, male, asian, stage:Stage I, alive, 415 days 134.6
TCGA-DD-AACB-01A 74 years, female, asian, stage:Stage I, alive, 2324 days 133.9
TCGA-G3-A5SK-01A 58 years, male, white, stage:Stage I, alive, 744 days 133.1
TCGA-DD-A4NL-01A 46 years, male, white, stage:Stage I, alive, 1711 days 132.9
TCGA-RC-A6M5-01A 20 years, female, white, stage:Stage IVA, alive, 15 days 131.8
TCGA-CC-5258-01A 48 years, male, asian, stage:Stage II, dead, 129 days 131.6
TCGA-DD-AADJ-01A 70 years, female, asian, stage:Stage I, alive, 1066 days 130.2
TCGA-EP-A2KB-01A 46 years, female, white, stage:Stage I, dead, 596 days 129.9
TCGA-MI-A75C-01A 64 years, male, white, stage:Stage I, alive, 291 days 129.5
TCGA-DD-AAE6-01A 59 years, female, asian, stage:Stage I, alive, 141 days 129.4
TCGA-DD-AACC-01A 61 years, male, asian, stage:Stage I, dead, 1685 days 129.3
TCGA-EP-A3JL-01A 76 years, male, white, stage:Stage I, alive, 303 days 129.2
TCGA-ED-A66Y-01A 51 years, female, asian, stage:Stage IIIA, dead, 296 days 128.7
TCGA-CC-A8HT-01A 74 years, male, asian, stage:Stage IIIA, dead, 140 days 128.7
TCGA-XR-A8TD-01A 49 years, female, white, stage:Stage IIIB, alive, 1030 days 126.7
TCGA-K7-A5RG-01A 66 years, male, black or african american, stage:Stage I, alive, 519 days 126.5
TCGA-G3-AAV0-01A 58 years, male, asian, stage:Stage I, alive, 476 days 126.5
TCGA-CC-A7II-01A 54 years, male, asian, stage:Stage IIIA, alive, 399 days 126.4
TCGA-WX-AA44-01A 64 years, female, white, stage:Stage I, alive, 615 days 125.4
TCGA-DD-A4NB-01A 25 years, male, white, stage:Stage I, alive, 989 days 125.3
TCGA-DD-AADR-01A 58 years, male, asian, stage:Stage I, alive, 2028 days 123.8
TCGA-K7-A6G5-01A 66 years, male, white, stage:Stage I, alive, 512 days 122.7
TCGA-WX-AA46-01A 61 years, male, white, stage:Stage II, alive, 756 days 121.9
TCGA-DD-A3A3-01A 45 years, male, asian, stage:Stage I, dead, 535 days 120.1
TCGA-DD-AACH-01A 69 years, male, asian, stage:Stage II, dead, 195 days 119.4
TCGA-DD-AAE9-01A 69 years, male, asian, stage:Stage I, alive, 722 days 118.7
TCGA-LG-A9QD-01A 68 years, male, white, stage:Stage IIIA, alive, 366 days 118.5
TCGA-ES-A2HT-01A 54 years, male, black or african american, stage:Stage I, dead, 438 days 118.1
TCGA-DD-AAVX-01A 38 years, male, asian, stage:Stage II, alive, 1718 days 118.1
TCGA-CC-A3MC-01A 54 years, male, asian, stage:Stage IIIA, alive, 363 days 116.6
TCGA-DD-AACQ-01A 50 years, male, asian, stage:Stage II, dead, 432 days 116.0
TCGA-BC-A110-01A 51 years, female, black or african american, stage:'--, dead, 2116 days 114.7
TCGA-G3-A3CH-01A 53 years, male, asian, stage:Stage IIIA, alive, 780 days 114.3
TCGA-DD-AAD5-01A 54 years, male, asian, stage:Stage I, alive, 1345 days 113.7
TCGA-DD-A4NP-01A 32 years, male, white, stage:Stage I, alive, 3308 days 111.4
TCGA-DD-A39Y-01A 67 years, male, asian, stage:Stage I, dead, 171 days 111.3
TCGA-DD-AADU-01A 60 years, male, asian, stage:Stage II, alive, 554 days 110.0
TCGA-DD-AAE0-01A 45 years, female, asian, stage:Stage IIIA, alive, 555 days 107.8
TCGA-KR-A7K2-01A 64 years, male, white, stage:Stage I, alive, 829 days 107.0
TCGA-DD-AACE-01A 62 years, male, asian, stage:Stage I, alive, 2184 days 107.0
TCGA-NI-A4U2-01A 71 years, male, white, stage:Stage IIIA, dead, 1791 days 106.5
TCGA-DD-AADM-01A 58 years, male, asian, stage:Stage II, dead, 12 days 106.5
TCGA-ED-A8O6-01A 50 years, female, asian, stage:Stage IIIA, dead, 56 days 106.3
TCGA-WJ-A86L-01A 68 years, female, white, stage:Stage I, alive, 345 days 106.3
TCGA-KR-A7K7-01A 61 years, female, white, stage:Stage II, alive, 951 days 106.1
TCGA-HP-A5MZ-01A 78 years, male, stage:Stage I, dead, 91 days 105.6
TCGA-DD-AAVU-01A 46 years, male, asian, stage:Stage II, alive, 2202 days 105.4
TCGA-DD-A73G-01A 73 years, female, white, stage:Stage I, alive, 3478 days 103.3
TCGA-DD-A3A7-01A 67 years, male, stage:Stage IIIB, dead, 419 days 101.8
TCGA-G3-AAUZ-01A 48 years, male, stage:Stage I, alive, 480 days 100.9
TCGA-CC-A7IG-01A 47 years, male, asian, stage:Stage II, dead, 299 days 100.5
TCGA-RC-A7S9-01A 47 years, female, asian, stage:Stage I, alive, 640 days 98.1
TCGA-CC-A7IF-01A 59 years, male, asian, stage:Stage IIIA, dead, 649 days 97.1
TCGA-RC-A7SF-01A 66 years, male, asian, stage:Stage I, alive, 579 days 96.2
TCGA-2Y-A9H3-01A 45 years, male, white, stage:Stage II, alive, 1516 days 95.9
TCGA-BC-A216-01A 62 years, female, white, stage:Stage IIIA, alive, 1351 days 95.9
TCGA-DD-AAEA-01A 65 years, male, asian, stage:Stage I, alive, 575 days 94.5
TCGA-DD-AACO-01A 40 years, male, asian, stage:Stage I, alive, 1876 days 93.5
TCGA-CC-A3MA-01A 61 years, male, asian, stage:Stage IIIA, dead, 303 days 91.9
TCGA-DD-AAE4-01A 49 years, female, asian, stage:Stage I, alive, 608 days 91.6
TCGA-DD-AADF-01A 64 years, female, asian, stage:Stage I, dead, 115 days 91.6
TCGA-DD-A116-01A 68 years, male, asian, stage:Stage IIIA, dead, 1622 days 89.4
TCGA-DD-A39X-01A 78 years, female, white, stage:Stage I, dead, 1694 days 88.4
TCGA-DD-AADQ-01A 59 years, male, asian, stage:Stage II, alive, 436 days 88.1
TCGA-FV-A495-01A 51 years, female, white, stage:Stage II, alive, 1 days 87.4
TCGA-ED-A7PY-01A 20 years, female, asian, stage:Stage II, alive, 390 days 85.8
TCGA-DD-AACI-01A 69 years, male, asian, stage:Stage II, alive, 1618 days 83.1
TCGA-DD-AAD6-01A 66 years, male, asian, stage:Stage IIIA, alive, 672 days 82.3
TCGA-WQ-AB4B-01A 62 years, male, white, stage:Stage II, alive, 395 days 81.5
TCGA-DD-AADA-01A 66 years, female, asian, stage:Stage I, alive, 1233 days 81.4
TCGA-G3-A3CJ-01A 52 years, male, american indian or alaska native, stage:Stage II, alive, 594 days 81.2
TCGA-DD-A39V-01A 77 years, male, white, stage:Stage II, dead, 643 days 80.8
TCGA-DD-AADS-01A 63 years, male, asian, stage:Stage I, alive, 474 days 80.8
TCGA-DD-AAVR-01A 44 years, male, asian, stage:Stage I, alive, 2513 days 80.2
TCGA-DD-A4NG-01A 77 years, male, white, stage:Stage IIIA, dead, 802 days 80.0
TCGA-DD-AAD8-01A 73 years, female, asian, stage:Stage I, alive, 1219 days 77.7
TCGA-ES-A2HS-01A 80 years, male, white, stage:Stage I, dead, 688 days 77.1
TCGA-CC-A5UC-01A 63 years, male, asian, stage:Stage IIIA, dead, 347 days 76.8
TCGA-5R-AA1D-01A 17 years, female, white, stage:Stage IIIA, alive, 449 days 75.6
TCGA-CC-A123-01A 24 years, female, asian, stage:Stage IIIA, alive, 219 days 72.4
TCGA-FV-A4ZP-01A 78 years, male, white, stage:Stage IIIA, dead, 2486 days 70.6
TCGA-DD-A119-01A 40 years, male, asian, stage:Stage IV, dead, 223 days 69.2
TCGA-CC-A7IE-01A 57 years, male, asian, stage:Stage IIIA, dead, 217 days 67.8
TCGA-WQ-A9G7-01A 71 years, female, white, stage:'--, alive, 30 days 67.7
TCGA-MR-A8JO-01A 34 years, male, white, stage:Stage I, alive, 330 days 67.4
TCGA-DD-AAEB-01A 60 years, male, asian, stage:Stage I, alive, 478 days 64.5
TCGA-CC-A8HV-01A 51 years, female, asian, stage:Stage II, dead, 279 days 61.5
TCGA-2Y-A9H1-01A 58 years, male, white, stage:Stage I, dead, 1229 days 59.4
TCGA-DD-AACG-01A 52 years, male, asian, stage:Stage II, dead, 469 days 55.7
TCGA-DD-AACD-01A 48 years, male, asian, stage:Stage I, dead, 381 days 54.1
TCGA-DD-AADO-01A 55 years, male, asian, stage:Stage I, alive, 453 days 53.3
TCGA-DD-A3A6-01A 72 years, female, white, stage:Stage II, dead, 3258 days 50.5
TCGA-DD-AADN-01A 59 years, male, asian, stage:Stage I, alive, 898 days 43.9
TCGA-DD-AAED-01A 51 years, male, asian, stage:Stage I, alive, 763 days 40.9
TCGA-RC-A7SH-01A 42 years, male, asian, stage:Stage II, alive, 468 days 38.8
TCGA-WX-AA47-01A 33 years, female, white, stage:Stage IIIA, dead, 556 days 31.0
TCGA-CC-5259-01A 60 years, female, asian, stage:Stage IIIC, alive, 250 days 22.2
Show allShow less
LIVER HEPATOCELLULAR CARCINOMA (VALIDATION) - Interactive survival scatter ploti

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisi

Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.

OS9 is not prognostic in Liver Hepatocellular Carcinoma (validation)


Stage:
Survival analysis
Current cut offi

Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.

:
Best expression cut offi

Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .

When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.

: 219.12
Median expressioni

Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.

: N/A
Median follow up timei

Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.

: N/A
P scorei

Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.

N/A
5-year survival highi

5-year survival for patients with higher expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
5-year survival lowi

5-year survival for patients with lower expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
TCGA RNA samplesi

RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .

Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.

Average pTPM 230.6
Number of samples 231
Samples
Sample Description pTPM
DO45127 73 years, male, NA, stage:3, dead, 420 days 591.9
DO45263 67 years, male, NA, stage:3, dead, 270 days 551.9
DO50829 78 years, male, NA, stage:3, alive, 570 days 533.9
DO45205 67 years, female, NA, stage:2, dead, 90 days 521.1
DO45275 65 years, male, NA, stage:3, dead, 10 days 509.5
DO45193 68 years, female, NA, stage:4, dead, 120 days 481.1
DO45185 89 years, male, NA, stage:2, alive, 600 days 444.7
DO48701 78 years, male, NA, stage:2, alive, 780 days 444.5
DO45155 69 years, male, NA, stage:2, alive, 2160 days 431.3
DO45209 70 years, male, NA, stage:4, alive, 1350 days 411.1
DO45092 62 years, male, NA, stage:4, dead, 1200 days 394.6
DO45111 74 years, male, NA, stage:2, alive, 1590 days 376.6
DO45191 61 years, female, NA, stage:2, alive, 1200 days 373.9
DO45245 75 years, female, NA, stage:2, dead, 240 days 364.3
DO45096 69 years, male, NA, stage:2, dead, 1290 days 362.4
DO48742 76 years, male, NA, stage:2, alive, 600 days 356.8
DO50819 72 years, female, NA, stage:2, alive, 510 days 354.7
DO48677 58 years, male, NA, stage:3, alive, 1140 days 352.7
DO23509 60 years, male, NA, stage:3, dead, 780 days 338.2
DO48681 57 years, male, NA, stage:2, alive, 900 days 335.0
DO45277 64 years, male, NA, stage:3, alive, 600 days 332.9
DO45179 78 years, female, NA, stage:2, alive, 600 days 330.9
DO23511 83 years, female, NA, stage:3, dead, 180 days 329.1
DO23515 71 years, male, NA, stage:2, alive, 1230 days 327.0
DO23533 61 years, male, NA, stage:2, alive, 900 days 324.8
DO23529 72 years, male, NA, stage:4, alive, 930 days 323.3
DO23513 76 years, male, NA, stage:3, alive, 1200 days 321.8
DO23521 63 years, male, NA, stage:3, alive, 1110 days 314.9
DO45303 62 years, female, NA, stage:3, alive, 990 days 314.8
DO50789 73 years, female, NA, stage:2, alive, 570 days 311.0
DO48732 73 years, male, NA, stage:3, alive, 630 days 310.6
DO50832 73 years, male, NA, stage:3, alive, 90 days 303.3
DO45189 85 years, female, NA, stage:2, alive, 1200 days 303.3
DO23537 79 years, male, NA, stage:2, dead, 900 days 303.2
DO48715 58 years, female, NA, stage:2, dead, 690 days 302.8
DO45115 81 years, male, NA, stage:2, alive, 840 days 301.5
DO45231 84 years, male, NA, stage:2, alive, 930 days 298.8
DO45249 57 years, male, NA, stage:1, alive, 630 days 298.3
DO45207 68 years, male, NA, stage:1, alive, 1050 days 297.9
DO45283 60 years, male, NA, stage:3, alive, 510 days 296.4
DO45255 81 years, male, NA, stage:3, alive, 720 days 295.1
DO45139 63 years, male, NA, stage:3, alive, 1320 days 294.3
DO50855 47 years, male, NA, stage:2, alive, 570 days 288.1
DO45237 58 years, male, NA, stage:2, alive, 900 days 286.8
DO45197 51 years, male, NA, stage:2, alive, 1170 days 286.1
DO23538 67 years, male, NA, stage:2, alive, 450 days 285.2
DO45259 65 years, male, NA, stage:3, alive, 330 days 283.9
DO45305 66 years, male, NA, stage:4, alive, 300 days 283.7
DO23525 71 years, male, NA, stage:4, alive, 1050 days 280.5
DO48743 69 years, female, NA, stage:2, alive, 570 days 279.0
DO50840 49 years, male, NA, stage:2, alive, 330 days 277.4
DO48717 54 years, male, NA, stage:4, dead, 180 days 276.4
DO45094 76 years, male, NA, stage:3, alive, 1650 days 275.8
DO23552 80 years, female, NA, stage:1, alive, 810 days 275.5
DO23523 52 years, male, NA, stage:3, alive, 1080 days 273.9
DO23526 66 years, male, NA, stage:3, alive, 1050 days 273.7
DO45183 72 years, female, NA, stage:2, dead, 570 days 273.5
DO23524 71 years, female, NA, stage:2, alive, 1050 days 272.9
DO50820 77 years, female, NA, stage:3, alive, 510 days 272.9
DO45159 65 years, male, NA, stage:3, alive, 1470 days 272.1
DO45133 64 years, male, NA, stage:3, dead, 660 days 271.2
DO45299 70 years, female, NA, stage:1, alive, 1440 days 270.5
DO45167 67 years, male, NA, stage:2, dead, 1440 days 268.4
DO45097 69 years, male, NA, stage:3, alive, 1620 days 267.4
DO45223 67 years, male, NA, stage:4, alive, 1020 days 266.2
DO23530 53 years, male, NA, stage:4, dead, 180 days 265.2
DO48719 80 years, male, NA, stage:2, alive, 690 days 263.3
DO48747 62 years, male, NA, stage:3, alive, 540 days 260.9
DO23512 60 years, male, NA, stage:1, alive, 1260 days 259.9
DO45225 69 years, male, NA, stage:1, alive, 1050 days 259.6
DO48697 64 years, female, NA, stage:2, dead, 810 days 258.7
DO48727 81 years, female, NA, stage:2, dead, 390 days 253.7
DO48761 55 years, male, NA, stage:2, alive, 870 days 252.3
DO23516 69 years, male, NA, stage:3, dead, 20 days 250.6
DO45227 57 years, female, NA, stage:2, alive, 1020 days 250.3
DO45113 58 years, male, NA, stage:3, alive, 1560 days 248.2
DO48760 70 years, female, NA, stage:2, alive, 690 days 248.2
DO50778 60 years, male, NA, stage:4, alive, 630 days 248.0
DO50800 74 years, male, NA, stage:2, alive, 510 days 247.9
DO48682 72 years, female, NA, stage:3, dead, 120 days 246.6
DO45289 78 years, female, NA, stage:3, alive, 360 days 245.2
DO45307 54 years, female, NA, stage:4, dead, 240 days 244.1
DO50776 75 years, male, NA, stage:1, alive, 690 days 243.2
DO45173 63 years, male, NA, stage:3, alive, 1170 days 243.1
DO48679 72 years, male, NA, stage:2, alive, 1200 days 242.9
DO23550 69 years, male, NA, stage:1, alive, 990 days 242.4
DO45239 42 years, male, NA, stage:2, alive, 870 days 241.5
DO23527 72 years, male, NA, stage:1, alive, 1050 days 239.3
DO45131 53 years, male, NA, stage:4, dead, 360 days 236.3
DO48737 52 years, male, NA, stage:1, alive, 720 days 234.6
DO45157 62 years, male, NA, stage:2, alive, 1980 days 233.7
DO45163 76 years, male, NA, stage:2, alive, 960 days 233.1
DO45161 74 years, male, NA, stage:2, dead, 540 days 232.0
DO48746 76 years, male, NA, stage:3, alive, 570 days 230.6
DO50807 67 years, male, NA, stage:1, alive, 540 days 230.4
DO45117 73 years, female, NA, stage:2, dead, 1110 days 230.3
DO45279 67 years, male, NA, stage:3, alive, 1290 days 229.2
DO50857 72 years, male, NA, stage:2, alive, 210 days 228.5
DO48706 72 years, male, NA, stage:2, alive, 870 days 227.9
DO23518 67 years, male, NA, stage:2, alive, 1320 days 227.8
DO50818 65 years, male, NA, stage:2, alive, 510 days 226.5
DO45149 70 years, female, NA, stage:2, alive, 1260 days 226.0
DO45165 75 years, male, NA, stage:2, alive, 690 days 225.9
DO45297 61 years, female, NA, stage:4, dead, 1260 days 224.4
DO45273 62 years, male, NA, stage:2, alive, 480 days 222.4
DO50839 47 years, female, NA, stage:3, alive, 330 days 221.7
DO45119 74 years, male, NA, stage:3, dead, 510 days 221.5
DO45153 77 years, female, NA, stage:2, alive, 1380 days 220.1
DO45091 56 years, male, NA, stage:2, dead, 1320 days 219.1
DO48720 62 years, female, NA, stage:2, alive, 570 days 217.4
DO50859 77 years, male, NA, stage:2, alive, 180 days 215.7
DO23535 67 years, male, NA, stage:1, alive, 960 days 215.7
DO45177 81 years, female, NA, stage:3, alive, 1260 days 215.0
DO48741 64 years, male, NA, stage:3, alive, 240 days 213.9
DO23542 66 years, male, NA, stage:3, alive, 960 days 212.7
DO23510 80 years, female, NA, stage:2, alive, 870 days 212.3
DO45129 61 years, male, NA, stage:3, alive, 1470 days 212.2
DO50809 56 years, male, NA, stage:3, dead, 720 days 210.6
DO50787 63 years, male, NA, stage:3, alive, 480 days 209.7
DO50845 72 years, male, NA, stage:3, alive, 210 days 209.4
DO45141 73 years, male, NA, stage:2, alive, 1320 days 208.4
DO45171 56 years, male, NA, stage:3, alive, 600 days 208.0
DO45285 59 years, male, NA, stage:3, alive, 480 days 207.5
DO48751 68 years, male, NA, stage:2, dead, 480 days 205.7
DO50783 62 years, male, NA, stage:3, alive, 480 days 205.6
DO50850 74 years, male, NA, stage:3, alive, 720 days 205.1
DO23536 56 years, male, NA, stage:2, alive, 930 days 204.1
DO50806 70 years, male, NA, stage:4, alive, 540 days 203.3
DO50802 49 years, male, NA, stage:2, alive, 930 days 202.9
DO50793 76 years, male, NA, stage:4, alive, 540 days 202.9
DO45099 46 years, male, NA, stage:3, alive, 1590 days 201.5
DO45301 56 years, male, NA, stage:2, dead, 1440 days 200.9
DO45261 74 years, male, NA, stage:3, alive, 990 days 200.8
DO23549 74 years, male, NA, stage:3, alive, 990 days 197.9
DO45287 74 years, male, NA, stage:1, alive, 390 days 197.7
DO45281 83 years, male, NA, stage:4, alive, 750 days 197.1
DO45095 66 years, male, NA, stage:2, alive, 1620 days 194.6
DO50804 81 years, male, NA, stage:2, alive, 720 days 193.3
DO50803 62 years, female, NA, stage:1, alive, 540 days 192.8
DO50844 75 years, male, NA, stage:4, alive, 300 days 192.6
DO50799 66 years, female, NA, stage:2, alive, 540 days 192.5
DO23519 65 years, male, NA, stage:3, alive, 630 days 192.5
DO45215 65 years, male, NA, stage:2, alive, 1170 days 192.3
DO50808 68 years, male, NA, stage:2, alive, 570 days 192.3
DO48725 66 years, male, NA, stage:1, alive, 780 days 192.1
DO48723 73 years, male, NA, stage:1, alive, 600 days 192.0
DO45213 58 years, male, NA, stage:1, alive, 1200 days 191.7
DO48733 72 years, male, NA, stage:2, alive, 600 days 191.1
DO45123 78 years, female, NA, stage:2, dead, 570 days 190.9
DO45267 73 years, male, NA, stage:3, dead, 570 days 190.7
DO48757 68 years, female, NA, stage:3, alive, 480 days 189.7
DO227801 77 years, female, NA, stage:1, alive, 660 days 189.3
DO45269 59 years, male, NA, stage:3, alive, 750 days 189.3
DO23514 64 years, male, NA, stage:2, alive, 1290 days 189.0
DO48728 74 years, female, NA, stage:2, alive, 150 days 188.5
DO48730 73 years, female, NA, stage:2, alive, 630 days 188.3
DO45121 61 years, male, NA, stage:3, alive, 1530 days 187.8
DO45199 86 years, female, NA, stage:2, alive, 1350 days 187.7
DO50813 56 years, male, NA, stage:2, alive, 420 days 187.6
DO48695 77 years, male, NA, stage:2, alive, 720 days 185.4
DO45137 38 years, male, NA, stage:1, alive, 1320 days 183.2
DO48736 76 years, female, NA, stage:1, alive, 600 days 182.5
DO48693 71 years, male, NA, stage:2, alive, 900 days 181.6
DO50822 66 years, male, NA, stage:2, alive, 510 days 181.5
DO23548 78 years, female, NA, stage:1, alive, 840 days 180.5
DO45233 83 years, male, NA, stage:3, alive, 900 days 180.5
DO23545 67 years, male, NA, stage:2, dead, 570 days 180.2
DO23508 79 years, female, NA, stage:2, alive, 390 days 176.3
DO23540 73 years, male, NA, stage:1, alive, 750 days 176.1
DO45219 78 years, male, NA, stage:2, alive, 1080 days 176.0
DO23543 63 years, male, NA, stage:2, alive, 1020 days 175.0
DO45253 50 years, male, NA, stage:2, alive, 870 days 174.8
DO45229 74 years, male, NA, stage:1, alive, 990 days 173.9
DO45241 49 years, male, NA, stage:1, alive, 1080 days 170.5
DO23534 60 years, male, NA, stage:2, alive, 840 days 170.2
DO45181 84 years, female, NA, stage:2, alive, 1200 days 169.9
DO50785 37 years, male, NA, stage:4, dead, 90 days 169.4
DO48716 71 years, male, NA, stage:2, alive, 720 days 167.8
DO45143 69 years, male, NA, stage:3, alive, 1290 days 167.7
DO50774 68 years, female, NA, stage:2, alive, 720 days 166.6
DO50825 70 years, male, NA, stage:2, alive, 390 days 165.0
DO23541 65 years, male, NA, stage:2, alive, 930 days 164.9
DO50805 72 years, male, NA, stage:2, alive, 690 days 164.1
DO50798 77 years, male, NA, stage:3, dead, 30 days 163.4
DO227643 79 years, male, NA, stage:2, alive, 1260 days 162.4
DO23531 78 years, female, NA, stage:3, alive, 900 days 161.4
DO45101 63 years, male, NA, stage:2, alive, 1680 days 161.2
DO48700 78 years, female, NA, stage:2, alive, 810 days 161.1
DO45187 32 years, female, NA, stage:1, alive, 1260 days 160.9
DO23547 74 years, male, NA, stage:1, alive, 1020 days 160.8
DO50814 83 years, male, NA, stage:3, alive, 420 days 160.3
DO45235 68 years, female, NA, stage:1, alive, 900 days 159.1
DO23546 63 years, male, NA, stage:2, alive, 1050 days 158.3
DO50816 63 years, male, NA, stage:2, alive, 390 days 158.3
DO45265 73 years, male, NA, stage:3, alive, 1020 days 156.3
DO45093 71 years, male, NA, stage:2, dead, 720 days 155.2
DO23528 45 years, female, NA, stage:2, alive, 1020 days 154.5
DO45243 74 years, female, NA, stage:3, alive, 930 days 154.3
DO48674 80 years, male, NA, stage:2, alive, 1260 days 153.8
DO45251 57 years, female, NA, stage:2, alive, 900 days 153.3
DO45125 58 years, male, NA, stage:3, alive, 1680 days 153.0
DO45103 47 years, male, NA, stage:3, alive, 450 days 152.2
DO45169 74 years, male, NA, stage:3, alive, 1350 days 152.1
DO50811 62 years, male, NA, stage:1, alive, 450 days 149.4
DO23539 77 years, male, NA, stage:1, alive, 1110 days 149.4
DO48672 81 years, male, NA, stage:2, alive, 450 days 146.2
DO23517 62 years, male, NA, stage:2, alive, 1200 days 145.5
DO45135 77 years, male, NA, stage:1, alive, 1410 days 145.1
DO45107 63 years, female, NA, stage:2, alive, 1710 days 144.3
DO48759 73 years, male, NA, stage:3, alive, 720 days 144.2
DO45221 75 years, female, NA, stage:4, dead, 390 days 144.2
DO45211 76 years, male, NA, stage:3, alive, 240 days 144.0
DO45175 74 years, male, NA, stage:2, alive, 1140 days 143.1
DO48721 58 years, female, NA, stage:1, alive, 900 days 142.5
DO23551 73 years, male, NA, stage:3, dead, 150 days 140.0
DO50791 79 years, female, NA, stage:1, dead, 480 days 137.4
DO45203 71 years, female, NA, stage:2, alive, 1170 days 133.1
DO45201 49 years, male, NA, stage:1, alive, 900 days 132.4
DO48712 50 years, male, NA, stage:2, alive, 810 days 126.0
DO45109 63 years, male, NA, stage:2, alive, 1590 days 125.9
DO45247 31 years, female, NA, stage:2, alive, 210 days 125.6
DO50815 62 years, male, NA, stage:3, alive, 150 days 125.5
DO45217 69 years, female, NA, stage:3, dead, 270 days 125.3
DO48704 68 years, female, NA, stage:3, alive, 750 days 123.1
DO45257 46 years, male, NA, stage:3, alive, 810 days 122.3
DO50817 75 years, male, NA, stage:2, alive, 390 days 121.4
DO45105 61 years, male, NA, stage:1, alive, 1680 days 117.3
DO45145 78 years, male, NA, stage:3, dead, 60 days 117.1
DO45195 62 years, male, NA, stage:1, alive, 390 days 117.0
DO23544 67 years, male, NA, stage:2, alive, 960 days 111.4
DO23532 71 years, female, NA, stage:1, alive, 960 days 103.6
Show allShow less
LIVER HEPATOCELLULAR CARCINOMA - Protein relative expression (CPTAC)
Number of samples 330
Samples
Sample ID Sample type nRPX
445 Tumor 2.2
527 Tumor 1.8
813 Tumor 1.7
1027 Tumor 1.6
814 Normal 1.2
745 Tumor 1.1
873 Tumor 1.0
727 Tumor 1.0
737 Tumor 1.0
515 Tumor 1.0
227 Tumor 1.0
357 Tumor 1.0
523 Tumor 0.9
615 Tumor 0.9
257 Tumor 0.8
112 Tumor 0.8
863 Tumor 0.8
697 Tumor 0.8
533 Tumor 0.8
857 Tumor 0.7
977 Tumor 0.7
777 Tumor 0.7
423 Tumor 0.7
1015 Tumor 0.7
411 Tumor 0.7
433 Tumor 0.6
435 Tumor 0.6
473 Tumor 0.6
135 Tumor 0.6
463 Tumor 0.5
285 Tumor 0.5
431 Tumor 0.5
497 Tumor 0.5
471 Tumor 0.5
1043 Tumor 0.5
865 Tumor 0.5
231 Tumor 0.5
267 Tumor 0.4
481 Tumor 0.4
963 Tumor 0.4
957 Tumor 0.4
451 Tumor 0.3
365 Tumor 0.3
715 Tumor 0.3
393 Tumor 0.3
743 Tumor 0.3
823 Tumor 0.3
147 Tumor 0.3
141 Tumor 0.3
443 Tumor 0.3
271 Tumor 0.2
1021 Tumor 0.2
741 Tumor 0.2
975 Tumor 0.2
343 Tumor 0.2
361 Tumor 0.2
867 Tumor 0.2
913 Tumor 0.2
1044 Normal 0.2
131 Tumor 0.1
277 Tumor 0.1
755 Tumor 0.1
195 Tumor 0.1
387 Tumor 0.1
383 Tumor 0.1
1013 Tumor 0.1
467 Tumor 0.1
1041 Tumor 0.1
327 Tumor 0.1
696 Normal 0.1
877 Tumor 0.1
663 Tumor 0.1
526 Normal 0.1
756 Normal 0.1
187 Tumor 0.1
647 Tumor 0.0
425 Tumor 0.0
955 Tumor 0.0
493 Tumor 0.0
528 Normal 0.0
1016 Normal 0.0
427 Tumor 0.0
698 Normal 0.0
958 Normal 0.0
518 Normal 0.0
477 Tumor 0.0
851 Tumor 0.0
728 Normal 0.0
557 Tumor 0.0
375 Tumor 0.0
636 Normal 0.0
466 Normal 0.0
817 Tumor 0.0
351 Tumor 0.0
944 Normal 0.0
213 Tumor 0.0
436 Normal 0.0
627 Tumor 0.0
685 Tumor 0.0
864 Normal 0.0
982 Normal 0.0
964 Normal 0.0
1032 Normal 0.0
297 Tumor 0.0
943 Tumor 0.0
125 Tumor 0.0
912 Normal -0.1
137 Tumor -0.1
868 Normal -0.1
1042 Normal -0.1
516 Normal -0.1
514 Normal -0.1
881 Tumor -0.1
554 Normal -0.1
416 Normal -0.1
422 Normal -0.1
376 Normal -0.1
746 Normal -0.1
695 Tumor -0.1
937 Tumor -0.1
742 Normal -0.1
462 Normal -0.1
926 Normal -0.1
517 Tumor -0.1
723 Tumor -0.1
448 Normal -0.1
171 Tumor -0.1
415 Tumor -0.1
162 Normal -0.1
553 Tumor -0.1
866 Normal -0.1
534 Normal -0.1
484 Normal -0.1
967 Tumor -0.1
738 Normal -0.1
356 Normal -0.1
342 Normal -0.1
882 Normal -0.1
414 Normal -0.1
284 Normal -0.1
1046 Normal -0.1
824 Normal -0.1
785 Tumor -0.1
364 Normal -0.2
328 Normal -0.2
452 Normal -0.2
286 Normal -0.2
815 Tumor -0.2
1022 Normal -0.2
428 Normal -0.2
721 Tumor -0.2
818 Normal -0.2
858 Normal -0.2
261 Tumor -0.2
563 Tumor -0.2
641 Tumor -0.2
954 Normal -0.2
567 Tumor -0.2
861 Tumor -0.2
713 Tumor -0.2
221 Tumor -0.2
142 Normal -0.2
172 Normal -0.2
1014 Normal -0.2
298 Normal -0.2
426 Normal -0.2
952 Normal -0.2
635 Tumor -0.2
778 Normal -0.2
228 Normal -0.2
1045 Tumor -0.2
564 Normal -0.2
924 Normal -0.2
628 Normal -0.2
424 Normal -0.2
618 Normal -0.2
132 Normal -0.2
138 Normal -0.2
662 Normal -0.2
524 Normal -0.2
432 Normal -0.2
392 Normal -0.2
978 Normal -0.2
665 Tumor -0.2
446 Normal -0.2
128 Normal -0.2
546 Normal -0.2
918 Normal -0.2
161 Tumor -0.3
938 Normal -0.3
114 Normal -0.3
648 Normal -0.3
358 Normal -0.3
714 Normal -0.3
786 Normal -0.3
966 Normal -0.3
124 Normal -0.3
468 Normal -0.3
394 Normal -0.3
472 Normal -0.3
716 Normal -0.3
922 Normal -0.3
487 Tumor -0.3
965 Tumor -0.3
258 Normal -0.3
568 Normal -0.3
465 Tumor -0.3
278 Normal -0.3
816 Normal -0.3
953 Tumor -0.3
976 Normal -0.3
368 Normal -0.3
136 Normal -0.3
232 Normal -0.3
421 Tumor -0.3
474 Normal -0.3
862 Normal -0.3
461 Tumor -0.3
968 Normal -0.3
214 Normal -0.3
672 Normal -0.3
722 Normal -0.3
332 Normal -0.3
126 Normal -0.3
492 Normal -0.3
111 Normal -0.3
494 Normal -0.3
412 Normal -0.3
915 Tumor -0.3
573 Tumor -0.3
482 Normal -0.3
464 Normal -0.3
447 Tumor -0.3
212 Normal -0.3
344 Normal -0.3
186 Normal -0.3
444 Normal -0.3
434 Normal -0.3
572 Normal -0.3
661 Tumor -0.4
878 Normal -0.4
191 Tumor -0.4
671 Tumor -0.4
363 Tumor -0.4
455 Tumor -0.4
917 Tumor -0.4
1026 Normal -0.4
353 Tumor -0.4
981 Tumor -0.4
686 Normal -0.4
185 Tumor -0.4
874 Normal -0.4
188 Normal -0.4
314 Normal -0.4
538 Normal -0.4
525 Tumor -0.4
642 Normal -0.4
223 Tumor -0.4
884 Normal -0.4
744 Normal -0.4
852 Normal -0.4
666 Normal -0.4
914 Normal -0.4
574 Normal -0.4
513 Tumor -0.4
148 Normal -0.4
535 Tumor -0.4
388 Normal -0.4
536 Normal -0.4
362 Normal -0.4
262 Normal -0.4
984 Normal -0.4
355 Tumor -0.4
196 Normal -0.4
956 Normal -0.4
268 Normal -0.4
498 Normal -0.4
272 Normal -0.5
222 Normal -0.5
312 Normal -0.5
488 Normal -0.5
384 Normal -0.5
911 Tumor -0.5
341 Tumor -0.5
545 Tumor -0.5
313 Tumor -0.5
395 Tumor -0.5
558 Normal -0.5
1028 Normal -0.5
352 Normal -0.5
366 Normal -0.5
664 Normal -0.5
386 Normal -0.5
483 Tumor -0.5
616 Normal -0.5
983 Tumor -0.5
916 Normal -0.5
456 Normal -0.5
925 Tumor -0.5
617 Tumor -0.6
145 Tumor -0.6
354 Normal -0.6
478 Normal -0.6
224 Normal -0.6
923 Tumor -0.6
921 Tumor -0.6
123 Tumor -0.6
146 Normal -0.6
396 Normal -0.7
724 Normal -0.7
491 Tumor -0.7
127 Tumor -0.7
218 Normal -0.7
217 Tumor -0.7
331 Tumor -0.7
571 Tumor -0.7
113 Tumor -0.7
367 Tumor -0.7
537 Tumor -0.7
211 Tumor -0.8
283 Tumor -0.9
385 Tumor -0.9
883 Tumor -0.9
1031 Tumor -0.9
192 Normal -0.9
951 Tumor -0.9
311 Tumor -0.9
413 Tumor -0.9
1025 Tumor -0.9
391 Tumor -1.0
Show allShow less
LIVER CANCER - Protein expressioni

A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.

Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

 

Antibody stainingi

Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.

Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.


Antibody HPA013694

Antibody CAB011518
 Staining
  High
  Medium
  Low
  Not detected
 Intensity
  Strong
  Moderate
  Weak
  Negative
 Quantity
  >75%
  75%-25%
  <25%
  None
 Location
  Nuclear
  Cytoplasmic/membranous
  Cytoplasmic/membranous,nuclear
  None
Cholangiocarcinoma
Carcinoma, Hepatocellular, NOS

Contact

  • NEWS ARTICLES
  • PRESS ROOM

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS

The Human Protein Atlas

  • DOWNLOADABLE DATA
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg Foundation.


contact@proteinatlas.org